基于证据的标准,用于识别需要进行肝病查的有风险的个人
Fredrik Åberg1, Ville Männistö2,3, Juho Asteljoki4,5,6
1Transplantation and Liver Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
Hepatology communications
|March 21, 2025
概括
这项研究定义了肝纤维化查的实际风险因素,在识别患有肝脏相关事件风险的个体时达到90%以上的灵敏度. 这些发现支持有针对性的查,以改善人口健康结果.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 公共卫生 公共卫生
- 诊断策略 诊断策略
背景情况:
- 目前的肝纤维化查缺乏明确的肝纤维化查.
- 处于危险状态的人群.
- 标准. 标准. 标准. 标准. 标准. 标准. 标准.
研究的目的:
- 使用已确定的风险因素定义特定的,敏感的选入口标准.
- 建立针对性肝纤维化查的实用,可扩展的策略.
主要方法:
- 分析了来自芬兰和英国生物银行队列的46万多名个人中的1919个风险因素组合.
- 与医疗保健登记处链接数据,以评估10年肝硬化相关事件 (LRE) 风险.
- 在美国样本中使用肝硬度测量 (LSM) 验证的标准.
主要成果:
- 最佳标准包括危险的酒精使用,严重肥胖,代谢综合征或特定的肝酶/风险评分模式.
- 在预测LREs和高LSM (>12 kPa) 方面获得了>90%的灵敏度.
- 在某些人群中发现FIB-4指数的局限性.
结论:
- 一种廉价,基于风险因素的策略为向性肝纤维化查提供了高灵敏度.
- 这种方法对于改善人口肝脏健康来说是实用的和可扩展的.
- 对于初始查,需要更敏感的非侵入性纤维化试验.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
62
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
62
Diseases of the Liver and Gallbladder
409
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
409


